Organogenesis Holdings (ORGO) Debt to Equity (2017 - 2024)
Organogenesis Holdings (ORGO) has 8 years of Debt to Equity data on record, last reported at $0.22 in Q3 2024.
- For Q3 2024, Debt to Equity fell 8.67% year-over-year to $0.22; the TTM value through Sep 2024 reached $0.22, down 8.67%, while the annual FY2023 figure was $0.24, 10.78% down from the prior year.
- Debt to Equity reached $0.22 in Q3 2024 per ORGO's latest filing, down from $0.24 in the prior quarter.
- Across five years, Debt to Equity topped out at $1.87 in Q2 2020 and bottomed at $0.18 in Q1 2021.
- Average Debt to Equity over 5 years is $0.38, with a median of $0.26 recorded in 2023.
- Peak YoY movement for Debt to Equity: plummeted 90.06% in 2021, then soared 72.07% in 2022.
- A 5-year view of Debt to Equity shows it stood at $0.19 in 2020, then soared by 61.8% to $0.3 in 2021, then decreased by 12.45% to $0.27 in 2022, then dropped by 10.78% to $0.24 in 2023, then dropped by 6.17% to $0.22 in 2024.
- Per Business Quant database, its latest 3 readings for Debt to Equity were $0.22 in Q3 2024, $0.24 in Q2 2024, and $0.23 in Q1 2024.